Posts Tagged ‘COVID-19’
Supply chain during pandemic discussed at June Biotech Manufacturers Forum meetingÂ
Representatives of Merck and NCBIO discussed the supply-chain difficulties and issues the COVID-19 pandemic created for the bioscience industry at the quarterly NCBIO Biomanufacturers Forum meeting held Wednesday, June 1, at the NC Biotechnology Center.
Read MoreMedical Device Forum discusses current FDA regulatory environmentÂ
NCBIO members got an overview of the Food and Drug Administration’s regulatory environment for medical devices both during the pandemic and now at the NCBIO Medical Device Forum held May 11 at the NC Biotechnology Center.
Read MoreBIO’s fall Congressional preview
The summer calm is grinding to a halt as members of Congress have returned to D.C. for what is sure to be a busy legislative sprint that could potentially impact all sectors of the biotech industry.
Read MoreNCBIO Medical Device Forum covers product development during pandemic
Depending on people, being flexible and agile and remembering the lessons learned during this pandemic were some of the key points shared by the panelists participating in NCBIO’s Medical Device Forum held online Wednesday, May 19.
Read MoreVaccine patent waiver breaks faith with American companies, stifles innovation
Vaccine patent waiver breaks faith with American companies, stifles innovation NCBIO is extremely disappointed that the Biden administration has chosen to support waiving critical intellectual property protections for U.S. COVID-19 vaccines. This decision, known as a TRIPS waiver, breaks faith with American innovators, punishes the ingenuity of our life sciences industry and will delay the…
Read More